Evidence-Based Tightrope Walking: The 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
Restricted accessEditorialFirst published online March, 2017
Evidence-Based Tightrope Walking: The 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
AlexanderEK, PearceEN, BrentGA, BrownRS, ChenH, DosiouC, GrobmanW, LaurbergP, LazarusJH, MandelSJ, PeetersR, SullivanS. 2017. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid, 27:315–389.
2.
De GrootL, AbalovichM, AlexanderEK, AminoN, BarbourL, CobinRH, EastmanCJ, LazarusJH, LutonD, MandelSJ, MestmanJ, RovetJ, SullivanS. 2012. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 97:2543–2565.
3.
Stagnaro-GreenA, AbalovichM, AlexanderE, AziziF, MestmanJ, NegroR, NixonA, PearceEN, SoldinOP, SullivanS, WiersingaW; American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and the Postpartum. 2011. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid, 21:1081–1125.
4.
LiC, ShanZ, MaoJ, WangW, XieX, ZhouW, LiC, XuB, BiL, MengT, DuJ, ZhangS, GaoZ, ZhangX, YangL, FanC, TengW. 2014. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women?. J Clin Endocrinol Metab, 99:73–79.
5.
MediciM, de RijkeYB, PeetersRP, VisserW, de Muinck Keizer-SchramaSM, JaddoeVV, HofmanA, HooijkaasH, SteegersEA, TiemeierH, Bongers-SchokkingJJ, VisserTJ. 2012. Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R study. J Clin Endocrinol Metab, 97:646–652.
6.
MediciM, KorevaarTI, VisserWE, VisserTJ, PeetersRP. 2015. Thyroid function in pregnancy: what is normal?. Clin Chem, 61:704–713.
7.
MarakaS, MwangiR, McCoyRG, YaoX, SangaralinghamLR, Singh OspinaNM, O'KeeffeDT, De YcazaAE, Rodriguez-GutierrezR, CoddingtonCC3rd, StanMN, BritoJP, MontoriVM. 2017. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ, 356:i6865.
8.
KarakostaP, AlegakisD, GeorgiouV, RoumeliotakiT, FthenouE, VassilakiM, BoumpasD, CastanasE, KogevinasM, ChatziL. 2012. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab, 97:4464–4472.
9.
LiuH, ShanZ, LiC, MaoJ, XieX, WangW, FanC, WangH, ZhangH, HanC, WangX, LiuX, FanY, BaoS, TengW. 2014. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid, 24:1642–1649.
10.
KorevaarTI, Schalekamp-TimmermansS, de RijkeYB, VisserWE, VisserW, de Muinck Keizer-SchramaSM, HofmanA, RossHA, HooijkaasH, TiemeierH, Bongers-SchokkingJJ, JaddoeVW, VisserTJ, SteegersEA, MediciM, PeetersRP. 2013. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab, 98:4382–4390.
11.
YingH, TangYP, BaoYR, SuXJ, CaiX, LiYH, WangDF. 2016. Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus. Endocrine, 54:742–750.
12.
KorevaarTI, SteegersEA, PopVJ, BroerenMA, ChakerL, de RijkeYB, JaddoeVW, MediciM, VisserTJ, TiemeierH, PeetersRP. 2016. Thyroid autoimmunity impairs the thyroidal response to hCG: two population-based prospective cohort studies. J Clin Endocrinol Metab, 2016:jc20162942.
13.
NegroR, FormosoG, MangieriT, PezzarossaA, DazziD, HassanH. 2006. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab, 91:2587–2591.
14.
NazarpourS, Ramezani TehraniF, SimbarM, TohidiM, Alavi MajdH, AziziF. 2017. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol, 176:253–265.
15.
AndersenSL, LaurbergP. 2014. Antithyroid drugs and congenital heart defects: ventricular septal defect is part of the methimazole/carbimazole embryopathy. Eur J Endocrinol, 171:C1–C3.
16.
AndersenSL, OlsenJ, WuCS, LaurbergP. 2013. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocr Metab, 98:4373–4381.
17.
AndersenS, OlsenJ, LaurbergP. 2016. Antithyroid drug side effects in the population and pregnancy. JCEM, 101:1606–1614.
18.
YoshiharaA, NohJ, YamaguchiT, OhyeH, SatoS, SekiyaK, KosugaY, SuzukiM, MatsumotoM, KuniiY, WatanabeN, MukasaK, ItoK, ItoK. 2012. Treatment of Graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab, 97:2396–2403.
19.
VosXG, EndertE, ZwindermanAH, TijssenJGP, WiersingaWM. 2016. Predicting the risk of recurrence before the start of antithyroid drug therapy in patients with Graves’ hyperthyroidism. J Clin Endocr Metab, 101:1381–1389.
20.
NedreboBG, HolmPI, UhlvingS, SorheimJI, SkeieS, EideGE, HusebyeES, LienEA, AanderudS. 2002. Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves’ disease. Eur J Endocrinol, 147:583–589.
21.
YoshiharaA, NohJY, WatanabeN, MukasaK, OhyeH, SuzukiM, MatsumotoM, KuniiY, SuzukiN, KamedaT, IwakuK, KobayashiS, SuginoK, ItoK. 2015. Substituting potassium iodide for methimazole as the treatment for Graves’ disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan. Thyroid, 25:1155–1161.
22.
MomotaniN, HisaokaT, NohJ, IshikawaN, ItoK. 1992. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves disease complicated by pregnancy. J Clin Endocr Metab, 75:738–744.
23.
HallbergP, ErikssonN, IbanezL, Bondon-GuittonE, KreutzR, CarvajalA, LucenaMI, PonceES, MolokhiaM, MartinJ, AxelssonT, YueQY, MagnussonPK, WadeliusM, EuDAC collaborators. 2016. Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. Lancet Diabetes Endocrinol, 4:507–516.
24.
MarakaS, O'KeeffeDT, MontoriVM. 2015. Subclinical hypothyroidism during pregnancy—should you expect this when you are expecting?: A teachable moment. JAMA Intern Med, 175:1088–1089.
25.
CaseyB. 2016. Effect of treatment of maternal subclinical hypothyroidism or hypothyroxinemia on IQ in offspring; and NCT00388297. Am J Obstet Gynecol, 214:S2.
